GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

Rating:
Buy ACOR
up 56.57 %

Acorda Therapeutics, Inc. (ACOR) rated Buy with price target $39 by Lazard Capital Mkts

Posted on: Monday,  Jan 25, 2010  10:25 AM ET by Lazard Capital Mkts

Lazard Capital Mkts rated Buy Acorda Therapeutics, Inc. (NASDAQ: ACOR) on 01/25/2010. Previously Lazard Capital Mkts rated Buy Acorda Therapeutics, Inc. (NASDAQ: ACOR)
on 03/31/2009., when the stock price was $20.24. Since then, Acorda Therapeutics, Inc. has gained 56.57% as of 01/26/2016's recent price of $31.69.
If you would have followed the previous Lazard Capital Mkts's recommendation on ACOR, you would have gained 56.57% of your investment in 2492 days.

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Lazard Capital Markets’ goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Lazard Capital Markets’ industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/25/2010 10:25 AM Buy
None
28.13 39.00
as of 12/31/2010
1 Week down  -9.61 %
1 Month down  -9.27 %
3 Months down  -27.40 %
1 YTD down  -4.88 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/31/2009 11:25 AM Buy
None
20.24 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy